| Gadolinium-Based Agents Safe for MRI Use - Renal and Urology News |
|
|
Renal and Urology News Researchers at Emory University School of Medicine in Atlanta who studied 116 such patients who underwent MRI with a gadolinium-based contrast agent observed no decline in renal function or nephrogenic systemic fibrosis (NSF), a rare but serious |